Roles for glycosylation in the anti-inflammatory molecule CD59

Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, Davis SJ, Ferguson MA, Dwek RA. (1997), Biochem Soc Trans. 25, 1177-84

Characterisation of the low affinity interaction between rat cell adhesion molecules CD2 and CD48 by analytical ultracentrifugation

Silkowski H, Davis SJ, Barclay AN, Rowe AJ, Harding SE, Byron O. (1997), Eur Biophys J. 25, 455-62

CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics

van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ. (1997), J Exp Med. 185, 393-403.

Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59

Bodian DL, Davis SJ, Morgan BP, Rushmere NK. (1997), J Exp Med. 185, 507-16

The glycosylation of the complement regulatory protein, human erythrocyte CD59

Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, Davis SJ, Ferguson MA, Dwek RA. (1997), J Biol Chem. 272, 7229-44